StemPar Sciences Seals Backing from Troika VC

Troika Venture Capital has put an undisclosed amount into privately held StemPar Sciences Inc., a developer of cancer treatments. Troika Venture Capital is based in in Moscow. StemPar is based in San Francisco.

2 January 2013•4 mins read
Feature image
LinkedInXEmail
LinkedInXEmail